MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • White Papers
  • DeviceTalks
Home » Layoffs ahead as Urologix restructures

Layoffs ahead as Urologix restructures

January 9, 2014 By Brad Perriello Leave a Comment

Share
Layoffs ahead as Urologix restructures

Urologix (OCT:ULGX) said it will lay off an unspecified number of workers as it looks to pare more than $1.5 million from its annual budget.

Minneapolis-based Urologix, which makes the Cooled ThermoTherapy and Prostiva RF devices to treat benign prostatic hyperplasia, also issued its preliminary revenue numbers for its fiscal 2nd quarter. Sales are expected to be roughly $3.8 million for the 3 months ended Dec. 31, which would be a 12.7% decline compared with the same period in 2012.

Urologix also withdrew its outlook for the rest of fiscal 2014. The medical device company had said it expected to post sales of of $15 million to $17 million for the fiscal year.

The layoffs and restructuring are designed to "refocus the allocation of resources and improve company profitability," according to a press release. Urologix said it plans to reorganize its operating groups and deploy "a more focused sales team structure."

"The deployment is designed to focus our field sales and mobile organization on the company’s strongest urology partners. These accounts, together, represent approximately 90% of U.S. company revenue and have demonstrated improving trends in recent years. Importantly, we have also dedicated resources in our inside sales and customer service roles to provide continuing support to all current customers by leveraging the combined resources of this sales-support group," according to the release.

"This new organizational structure marks an important step towards repositioning Urologix for future growth and sustainability," CEO Greg Fluet said in prepared remarks. "In addition to refocusing our resources on our strongest urology partners, we believe these measures will lead to a more cost effective sales and operating infrastructure. Importantly, by leveraging our well-established, multi-tiered, distribution model, we expect to maintain our market-leading service levels throughout our existing account base of urologist practices. We expect this program to make the company stronger and to drive improving profitability and shareholder value going forward."

Urologix is slated to report its full fiscal 2nd-quarter results Feb. 4.

 

Filed Under: MassDevice Earnings Roundup, News Well, Urology Tagged With: Layoffs, Q4, Urologix Inc.

In case you missed it

  • Swiss heart valve dev Novostia raises $7m
  • Dexcom beats The Street with Q4, FY18 results
  • ViewRay wins FDA nod for MRIdian system soft tissue visualization capabilities
  • Boston Scientific prices $4.3m senior notes offering
  • Abbott touts real-world data for FreeStyle Libre glucose monitor
  • Mylan launches generic sublingual film for opioid dependence
  • Propeller Health study suggests 84% of asthma inhaler use performed incorrectly
  • LivaNova wins Japanese reimbursement for Perceval aortic valve
  • Acelity’s KCI launches Abthera NPWT system in Japan
  • ARS Pharmaceuticals wins fast track status for epinephrine nasal spray
  • Mauna Kea, Cook Medical terminate Cellvizio dev, distro deal
  • Axonics Modulation touts results of sacral neuromodulation study
  • CorMatrix launches FDA IDE Cor Tricuspid ECM cardiac valve trial
  • Philips wins FDA nod for DigitalDiagnost C90 digital radiography system
  • Teleflex shares dip on Q4, 2018 earnings release, restructuring announcement
  • Report: Medtronic to close Portsmouth, N.H. transformative solutions facility
  • Late mortality rates ‘inadvertently reversed’ in 5-year study of paclitaxel-eluting stent

RSS From Medical Design & Outsourcing

  • How to design home healthcare devices that people will use
    Meeting consumer demands for home healthcare technology requires a keen knowledge of user behavior. Here are four ways companies are approaching the market. by Scott Thielman, Product Creation Studio The global smart home healthcare market is exploding as more medical devices are designed for use wherever the patient is, including at home. A report by Research… […]
  • Axonics Modulation touts results of sacral neuromodulation study
    Axonics Modulation Technologies (NSDQ:AXNX) announced positive top-line results from a pivotal study of its novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction. The clinical study demonstrated that patients implanted with the Axonics r-SNM system experienced clinically meaningful and statistically significant improvements in urinary urgency incontinence (UUI) symptoms and quality of… […]
  • Okay Industries appoints new marketing manager
    Okay Industries (New Britain, Conn.) announced that it has appointed Angela Dillon as its new marketing manager. As marketing manager, Dillon willed strategic initiative that will promote the Okay brand, support business development and manage both internal and external communications for talent recruitment and retention. “I am excited to announce this new role for Angela,”… […]
  • SIG Medical wins FDA clearance for rib fracture device
    SIG Medical (Hershey, Penn.) has received FDA 510(k) clearance for its enhanced AdvantageRib System, the K183317. The system is the third rib fracture system from SIG Medical that has received 510(k) clearance recently and is being commercialized. The most recent 510(k) includes new implants that treat patients, as well as the entire spectrum of bone… […]
  • Starr Surgical signs strategic cooperation agreement with Smile Eyes
    Starr Surgical (Monrovia, Calif.) recently announced that it has signed a strategic cooperation agreement with the Smile Eyes group in Germany and Austria. The Smile Eyes group is an alliance of more than 80 eye experts in 13 vision correction eye centers in Germany and Austria. Through the agreement, EVO Visian ICL lenses will be… […]
  • Phillips-Medisize is offering connected health data services: Here’s how
    One of the world’s largest medical device contract manufacturers, Phillips-Medisize is making a business play to provide the technological back end for connected drug delivery devices. Phillips-Medisize used to be all about the housings, assembly and packaging that went into finished drug-delivery devices. Electronics was something that other contract manufacturers did. Within a few years,… […]
  • Summit Medical expands manufacturing facility
    Summit Medical recently announced that it has expanded its St. Paul, Minn. manufacturing facility with an additional 15,000 sq. ft. The addition opened on Feb. 11. The expansion will become a secondary facility for the company’s headquarters that is located less than a mile away. It will also serve as a master distribution center. “The… […]
  • AdvaMed president & CEO Scott Whitaker to participate in keynote interview at DeviceTalks Boston 2019
    WTWH Media and MassDevice.com announced today that Scott Whitaker, president and CEO of AdvaMed, will be a featured keynote speaker at DeviceTalks Boston 2019. DeviceTalks Boston, which takes place on June 5-6, 2019 at the Seaport World Trade Center, brings together engineering, product development and commercialization professionals to share the challenges and best practices of getting medical devices… […]
  • Apollo Endosurgery touts results of stomach-stapling study
      Apollo Endosurgery (NSDQ:APEN) has reported key data from 1,000 patients who underwent endoscopic gastroplasty using the company’s OverStitch device. Published in the journal Gastrointestinal Endoscopy, the data include a mean total weight loss of 14.8%±8.5% at 18 months. Three months following surgery, the impact on obesity-related comorbidities included the complete remission of: 13 of 17 cases… […]
  • Royal Philips introduces new C-arm imaging tech
    Royal Philips (NYSE:PHG) said it has launched a new mobile C-arm imaging platform, Zenition. Mobile C-arms are X-ray systems that are brought into the operating room (OR) to provide live image guidance during a wide range of surgeries including orthopedic, trauma and vascular procedures. The Zenition mobile C-arm platform brings together innovations in image capture, image… […]
  • When human factor specialists become the patient
    By Allison Strochlic, Emergo Group I just had a baby – my second daughter. This means that, like over 98% of my fellow American moms-to-be, I checked into a local hospital to have nurses and doctors oversee what I hoped would be the smooth delivery of my baby. This entitled me to the firsthand experience… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS